Company: SNSE
Filing Date: 2025-04-01
Form Type: PRE 14A
Source: 0000950170-25-048533
Chunk: 33

Company: Sensei Biotherapeutics, Inc.
Filing Date: 2025-04-01
Form: PRE 14A
Chunk 33
---
 prior to July 7, 2025, our Board may use its discretion to not carry out or to delay in carrying out the Reverse Stock Split.

In the event our Board delays its decision to execute the Reverse Stock Split and Authorized Shares Reduction because the Company has regained compliance with the minimum bid price requirement, if our common stock price again falls below $1.00 for a 30-day during the 12-month period following the Annual Meeting, and therefore again fails to comply with the applicable Nasdaq Capital Market minimum listing requirements, then the Reverse Stock Split may be executed as a cure for this condition.

Principal Effects Of Reverse Stock Split and Corresponding Proportionate Authorized Share Reduction on Outstanding Common Stock and Authorized Common Stock

The following table illustrates the effects of a 1-for-10, 1-for-20 and 1-for-30 Reverse Stock Split on our outstanding common stock as of March 15, 2025, without giving effect to any adjustments for fractional shares and information regarding our authorized shares based on the corresponding proportionate Authorized Shares Reduction:

<div align='center'>17</div>

| Reverse Stock Split Ratio                                               |     |           — |     | 10:1 |            |     | 20:1 |            |     | 30:1 |           |
| Number of Shares of Common Stock Authorized                             |     | 250,000,000 |     |      | 25,000,000 |     |      | 12,500,000 |     |      | 8,333,333 |
| Number of shares of Common Stock Issued and Outstanding                 |     |  25,208,068 |     |      |  2,520,806 |     |      |  1,260,403 |     |      |   840,268 |
| Number of Shares of Common Stock Reserved for Future Issuance           |     |   9,174,209 |     |      |    917,420 |     |      |    458,710 |     |      |   305,806 |
| Number of Shares of Common Stock Authorized but Unissued and Unreserved |     | 215,617,723 |     |      | 21,561,774 |     |      | 10,780,887 |     |      | 7,187,259 |

The Reverse Stock Split will affect all of our stockholders uniformly and will not materially affect any stockholder’s percentage ownership interests in the Company or proportion